The bird flu virus remains a wild card that continues to threaten U.S. poultry and egg supplies while upping the ante with risk to human health.

Citing concerns about mRNA technology, the Trump administration has pulled funding for a vaccine, even though Moderna says it ...

The Department of Health and Human Services is ending a $766 million contract with the vaccine company Moderna to develop an ...

MRNA technology is already used in Moderna’s and Pfizer/BioNTech’s currently licensed COVID-19 vaccines, which have been found to be safe and effective.

President Donald Trump on Wednesday issued a number of pardons and Secretary of State Marco Rubio announced the administration will work toward "aggressively revoke visas" for Chinese students at U.S.

Health Secretary Robert F. Kennedy Jr. has expressed deep skepticism regarding mRNA vaccines, despite real-world evidence that the vaccines are safe and saved millions of lives.

On Wednesday, as news broke that the Trump administration was reneging on the contract, Moderna reported positive results from an early trial of a vaccine targeting H5 influenza viruses. In a ...

The award from the Biomedical Advanced Research and Development Authority (BARDA), part of the US Department of Health and ...

The US has withdrawn $766 million in funding for Moderna's H5N1 vaccine amid a severe bird flu outbreak. This raises concerns ...

The Trump administration has canceled $766 million awarded to drugmaker Moderna Inc. to develop a vaccine against potential pandemic influenza viruses, including the H5N1 bird flu. The company said it ...

The department cited Moderna’s use of the messenger RNA technology, which it said “remains under-tested,” for the ...